鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/21 | 4,665 | 4,695 | 4,640 | 4,680 | +35 | +0.8% | 64,600 |
| 2025/01/20 | 4,580 | 4,675 | 4,560 | 4,645 | +65 | +1.4% | 93,700 |
| 2025/01/17 | 4,590 | 4,590 | 4,520 | 4,580 | ±0 | ±0% | 50,400 |
| 2025/01/16 | 4,595 | 4,670 | 4,580 | 4,580 | ±0 | ±0% | 78,100 |
| 2025/01/15 | 4,660 | 4,675 | 4,515 | 4,580 | -95 | -2% | 142,600 |
| 2025/01/14 | 4,700 | 4,715 | 4,640 | 4,675 | -50 | -1.1% | 86,000 |
| 2025/01/10 | 4,660 | 4,725 | 4,660 | 4,725 | +10 | +0.2% | 39,800 |
| 2025/01/09 | 4,650 | 4,725 | 4,650 | 4,715 | +50 | +1.1% | 39,200 |
| 2025/01/08 | 4,745 | 4,770 | 4,645 | 4,665 | -70 | -1.5% | 83,700 |
| 2025/01/07 | 4,705 | 4,735 | 4,680 | 4,735 | +75 | +1.6% | 68,900 |
| 2025/01/06 | 4,705 | 4,705 | 4,640 | 4,660 | -55 | -1.2% | 58,600 |
| 2024/12/30 | 4,765 | 4,780 | 4,680 | 4,715 | +20 | +0.4% | 81,100 |
| 2024/12/27 | 4,475 | 4,695 | 4,475 | 4,695 | +260 | +5.9% | 223,800 |
| 2024/12/26 | 4,450 | 4,505 | 4,425 | 4,435 | +10 | +0.2% | 83,000 |
| 2024/12/25 | 4,425 | 4,460 | 4,405 | 4,425 | -10 | -0.2% | 35,600 |
| 2024/12/24 | 4,430 | 4,445 | 4,395 | 4,435 | +30 | +0.7% | 43,800 |
| 2024/12/23 | 4,430 | 4,440 | 4,400 | 4,405 | +5 | +0.1% | 40,000 |
| 2024/12/20 | 4,445 | 4,465 | 4,385 | 4,400 | -45 | -1% | 84,400 |
| 2024/12/19 | 4,405 | 4,495 | 4,390 | 4,445 | +30 | +0.7% | 129,900 |
| 2024/12/18 | 4,505 | 4,510 | 4,405 | 4,415 | -95 | -2.1% | 93,900 |
| 2024/12/17 | 4,565 | 4,565 | 4,500 | 4,510 | -30 | -0.7% | 38,900 |
| 2024/12/16 | 4,605 | 4,620 | 4,535 | 4,540 | -60 | -1.3% | 73,300 |
| 2024/12/13 | 4,570 | 4,625 | 4,545 | 4,600 | ±0 | ±0% | 83,300 |
| 2024/12/12 | 4,600 | 4,655 | 4,590 | 4,600 | ±0 | ±0% | 69,400 |
| 2024/12/11 | 4,555 | 4,630 | 4,535 | 4,600 | +25 | +0.5% | 82,200 |
| 2024/12/10 | 4,660 | 4,685 | 4,545 | 4,575 | -30 | -0.7% | 88,700 |
| 2024/12/09 | 4,705 | 4,705 | 4,595 | 4,605 | -30 | -0.6% | 55,600 |
| 2024/12/06 | 4,720 | 4,750 | 4,610 | 4,635 | -105 | -2.2% | 62,200 |
| 2024/12/05 | 4,735 | 4,800 | 4,700 | 4,740 | +10 | +0.2% | 90,800 |
| 2024/12/04 | 4,665 | 4,770 | 4,620 | 4,730 | +15 | +0.3% | 85,700 |
| 2024/12/03 | 4,695 | 4,775 | 4,665 | 4,715 | -15 | -0.3% | 77,200 |
| 2024/12/02 | 4,820 | 4,835 | 4,710 | 4,730 | -105 | -2.2% | 76,800 |
| 2024/11/29 | 4,755 | 4,840 | 4,695 | 4,835 | +85 | +1.8% | 127,100 |
| 2024/11/28 | 4,830 | 4,840 | 4,710 | 4,750 | -55 | -1.1% | 79,400 |
| 2024/11/27 | 4,870 | 4,885 | 4,750 | 4,805 | -30 | -0.6% | 60,900 |
| 2024/11/26 | 4,775 | 4,855 | 4,745 | 4,835 | +60 | +1.3% | 142,100 |
| 2024/11/25 | 4,820 | 4,860 | 4,735 | 4,775 | +15 | +0.3% | 127,300 |
| 2024/11/22 | 4,635 | 4,760 | 4,545 | 4,760 | +95 | +2% | 185,500 |
| 2024/11/21 | 4,800 | 4,850 | 4,330 | 4,665 | -90 | -1.9% | 637,600 |
| 2024/11/20 | 4,795 | 4,820 | 4,690 | 4,755 | +30 | +0.6% | 199,900 |
| 2024/11/19 | 4,700 | 4,850 | 4,675 | 4,725 | +10 | +0.2% | 251,100 |
| 2024/11/18 | 4,650 | 4,775 | 4,580 | 4,715 | +135 | +2.9% | 305,400 |
| 2024/11/15 | 4,570 | 4,630 | 4,425 | 4,580 | +25 | +0.5% | 499,100 |
| 2024/11/14 | 4,415 | 4,575 | 4,365 | 4,555 | +200 | +4.6% | 149,500 |
| 2024/11/13 | 4,400 | 4,415 | 4,315 | 4,355 | -50 | -1.1% | 148,600 |
| 2024/11/12 | 4,130 | 4,420 | 4,130 | 4,405 | +135 | +3.2% | 116,500 |
| 2024/11/11 | 4,235 | 4,465 | 4,235 | 4,270 | +20 | +0.5% | 567,700 |
| 2024/11/08 | 4,115 | 4,275 | 4,110 | 4,250 | +135 | +3.3% | 75,800 |
| 2024/11/07 | 4,250 | 4,270 | 4,115 | 4,115 | -85 | -2% | 86,100 |
| 2024/11/06 | 4,175 | 4,325 | 4,175 | 4,200 | +60 | +1.4% | 96,300 |
51～
100
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
